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United KingdomHucke and colleagues are to be congratulated on their work pre-
dicting likely response to multiple cycles of transarterial chemo-
embolization (TACE) [1]. However, there are some issues that
need addressing.
Firstly, the authors assert that the ART score is derived from 3
variables. This is not true. The Child-Pugh score itself consists of 5
variables thus, it actually consists of 7 variables. In addition, the
greatest weighting for the ART score is not placed on evidence of
radiological response but on evidence of progressive cirrhosis and
worsening liver synthetic function. A rising aspartate amino-
transferase (AST) is well documented in advanced disease as a
marker of more severe cirrhosis [2,3]. It would have been useful
to have seen the individual biochemical constituents of the Child-
Pugh score and assessed their impact on predicting outcome.
An alternative score for predicting patient outcome after TACE
is available. The hepatoma arterial-embolization prognostic score
(HAP) was derived to assess likely response to TACE [4]. The score
was derived from a training set of 114 patients from which the
score was developed, and then validated in an independent sam-
ple of 167 patients. Patients were assigned 1 point for albumin
<36 g/dl, bilirubin >17 lmol/l, AFP >400 ng/ml, or size of domi-
nant lesion >7 cm, and has the advantage of not relying on assess-
ment of response to previous TACE. The score was calculated by
adding up their respective points. Patients were then divided into
four groups: HAP score 0 = A, HAP 1 = B, HAP 2 = C, HAP >2 = D.
The median survival for the respective groups was 27.6 months,
18.5 months, 9 months, and 3.6 months. Future studies in this
ﬁeld should compare the performance of both the ART strategy
and the HAP score to determine their applicability and how they
could best be used to help our patients.Journal of Hepatology 20
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